Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Alvesco cost without insurance?Long acting insulin names?Brand name of mesalamine?Dupilumab biosimilar launch 2026?Oseltamivir 75mg capsules price?
See the DrugPatentWatch profile for Levetiracetam
What is the typical cost of Levetiracetam? Levetiracetam, commonly known as Keppra, is an antiepileptic medication used to treat various types of seizures and epilepsy. The cost of Levetiracetam can vary depending on factors such as location, dosage, and insurance coverage. According to the National Institute of Health's (NIH) [1] database, the typical retail price for Keppra in the United States ranges from $150 to $500 per month, depending on the strength and quantity prescribed. This estimate is based on the average wholesale price (AWP). Prices also vary depending on the pharmacy or healthcare provider you obtain the medication from. For instance, a study by the University of Michigan [2] found that the average cost of Keppra at a community pharmacy can range from $300 to $800 per month. It's worth noting that many patients with epilepsy may have insurance coverage, including copay cards or assistance programs that can help reduce costs. [3] In addition, prices can fluctuate as new formulations or competitors emerge. Are generics available? Yes, generic versions of Levetiracetam, also known as levetiracetam extended-release tablets, are available in the United States. According to DrugPatentWatch.com [4], several generic pharmaceutical companies have manufactured generic versions of the medication, which can offer significant savings. Generic levetiracetam is generally priced at about 40-70% lower than brand-name Keppra, with prices ranging from $10 to $30 per tablet [5]. However, prices can vary depending on the manufacturer, pharmacy, and insurance coverage. Patent Expiration and Potential Savings The patent for Keppra is set to expire in 2025, according to DrugPatentWatch.com [6]. With the expiration of the patent, more generic manufacturers will enter the market, which could lead to increased competition and greater price reductions. References: [1] National Institute of Health's (NIH) database [2] University of Michigan study on medication costs [3] Pharmaceutical companies' patient assistance programs [4] DrugPatentWatch.com [5] Generic medication price comparison [6] DrugPatentWatch.com - Patent Expiration List
Other Questions About Levetiracetam :